Action HHI HEALTH HOUSE INTERNATIONAL
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Health House International

Actions

HHI

AU0000141368

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Health House International to be Removed from Australian Bourse's Official List
Creso Pharma Limited completed the acquisition of Health House International Limited.
Health House International Discloses Release of Shares from Escrow
Health House International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
Health House International Limited Auditor Raises 'Going Concern' Doubt
Health House International CEO to Step Down
Health House International Limited Announces Resignation of Paul Mavor as COO, Effective 2 December 2022
Health House International Limited Announces Resignation of David Attwood, CEO, Effective 19 March 2023
COVID-19 Resurgence in China Pushes Down Australian Shares
Creso Pharma Signs Deal to Acquire Health House; Creso Shares Fall 9%
Health House International Limited Announces Resignation of Henrik Sprengel as Executive Director
Sabine Jacker completed the acquisition of THCinol/CBDinol CanPharma GmbH from Health House International Limited.
Health House International Selling German Subsidiary for $0.99
Sabine Jacker executed a binding terms sheet to accquire THCinol/CBDinol CanPharma GmbH from Health House International Limited for Ç1.
Health House International Limited announced that it has received AUD 0.4 million in funding from Celtic Capital Pty. Ltd.
Health House International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Health House Subsidiary Secures Supply of Cannabis Extract for German Market
Creso Pharma Limited signed a non-binding term sheet to acquire Health House International Limited for AUD 5.3 million.
Zelira Therapeutics Limited cancelled the acquisition of Health House International Limited.
Health House International Posts 8.4% Growth in Fiscal Q2 Cash Receipts
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HHI
  4. Actualités Health House International
  5. Autres langues